Feasibility and acceptability of G6PD testing and radical cure for Plasmodium vivax in Cambodia: the VIGTARC study – User Guide

Permanent identifier

https://doi.org/10.17037/DATA.00002333

Description

This study aimed to design, implement and evaluate a new care pathway for P.v. malaria in Pursat province, Cambodia. Patients diagnosed with P.v infection by Village Malaria Workers (VMWs) were referred to local health centres for point-of-care G6PD testing and initiation of radical cure treatment depending on G6PD status. Primaquine was administered as 14 daily doses or 8 weekly doses of primaquine depending on G6PD status, with counselling and community follow-up including directly observed therapy by the VMW. Feasibility and acceptability were evaluated using a mixed methods approach.

Contact

Please direct all correspondence on this dataset to Professor Shunmay Yeung.

Key dates

• Project start date: February 2019
• Data collection period: February 2019 - 30 June 2021
• Data completed: 30 June 2022

Population

Patients diagnosed with P.v infection by Village Malaria Workers (VMWs) located in Pursat province, Cambodia.

Privacy

The data depositor, Rosemarie Ridley, has removed identifiable information.

Ethics

Keywords

Malaria

Language of written material

English

Creators

Qualitative transcripts